LLNL National Resource for Biomedical Accelerator Mass Spectrometry
Resource Description
Accelerator Mass Spectrometry
Biological AMS
Resource Equipment
Resource Access
Application and Review
Letters of Intent
Business and Contracts
Sample Submission
Acknowledgements
Annual Review
Visiting the Resource
Resource Staff
Contact Us
Privacy & Legal Notice
Home

Publications, Presentations and Acknowledgment of the Resource

As a condition for your use of the Biomedical AMS Resource, it is expected that you will pursue publication of the results within one year of successful completion of the studies. When using data in publications and/or presentations, you must acknowledge NIH Resource for Biomedical Accelerator Mass Spectrometry and the supporting grant(s) per the funding agency and grant number(s).

All publications must acknowledge the participation of the Resource and contain the following acknowledgment statement:

"Work performed (partially) at the Research Resource for Biomedical AMS which is operated at LLNL under the auspices of the U.S. Department of Energy under contract # W-7405-ENG-48. The Research Resource is supported by the National Institutes of Health, National Center for Research Resources, Biomedical Technology Program grant #P41 RR13461."

Copies of preprints should be sent to the Resource Administrator for review by Resource collaborator or staff. After publication, an electronic and two hardcopies reprints need to be sent to the Resource Administrator.

For NIH reporting purposes, we require up-to-date publication listings from all collaborators, service users and Resource staff for work to which the Resource has contributed. These publication lists are extremely important in presenting our scientific achievements, technology capabilities and productivity to the National Center for Research Resources and our Advisory Committee.

Biomedical AMS Research Resource Publications

    1. Buchholz BA, Freeman SPHT, Haack KW and Vogel JS (2000). Tips and traps in the C-14 bio-AMS preparation laboratory. Nuclear Instruments & Methods in Physics Research, Section B-Beam Interactions with Materials & Atoms 172 : 404-408.

    2. Buchholz BA, Dueker SR, Lin YM, Clifford AJ and Vogel JS (2000). Methods and applications of HPLC-AMS. Nuclear Instruments & Methods in Physics Research, Section B-Beam Interactions With Materials and Atoms 172 : 910-914.

    3. Ognibene TJ, Brown TA, Knezovich JP, Roberts ML, Southon JR and Vogel JS (2000). Ion-optics calculations of the LLNL AMS system for biochemical C-14 measurements. Nuclear Instruments & Methods in Physics Research , Section B-Beam Interactions With Materials and Atoms 172 : 47-51.

    4. Roberts ML, Hamm RW, Dingley KH, Chiarappa-Zucca ML and Love AH (2000). A compact tritium AMS system. Nuclear Instruments & Methods in Physics Research, Section B-Beam Interactions with Materials & Atoms 172 : 262-267.

    5. Shan G, Huang W, Gee SJ, Buchholz BA, Vogel JS and Hammock BD (2000). Isotope-labeled immunoassays without radiation waste. Proc. Natl. Acad. Sci. U.S.A. 97(6) : 2445-2449.

    6. Dueker SR, Lin YM, Buchholz BA, Schneider PD, Lame MW, Segall HJ, Vogel JS and Clifford AJ (2000). Long-term kinetic study of beta-carotene, using accelerator mass spectrometry in an adult volunteer. J. Lipid Res. 41(11) : 1790-1800.

    7. Goldman R, Day BW, Carver TA, Mauthe RJ, Turteltaub KW and Shields PG (2000). Quantitation of benzo[a]pyrene-DNA adducts by postlabeling with 14C-acetic anhydride and accelerator mass spectrometry. Chem. Biol. Interact . 126(3) :171-83.

    8. Phillips DH, Farmer PB, Beland FA, Nath RG, Poirier MC, Reddy MV, and Turteltaub KW (2000). Methods of DNA Adduct Determination and their Application to Testing Compounds for Genotoxicity Environ. Mol. Mutagen. 35 : 222-233.

    9. Turteltaub Kenneth W and Vogel John S (2000). Bioanalytical Applications of Accelerator Mass Spectrometry for Pharmaceutical Research. Curr. Pharm. Design , 6 : 991-1007.

    10. Vogel, J. S. (2000). Accelerator mass spectrometry for human biochemistry: The practice and the potential. Nuclear Instruments & Methods in Physics Research Section B-Beam Interactions With Materials and Atoms 172 : 884-891.

    11. Miyashita M, Presley JM, Buchholz BA, Lam KS, Lee YM, Vogel JS, and Hammock BD (2001). Attomole level protein sequencing by Edman degradation coupled with accelerator mass spectrometry. Proc. Natl. Acad. Sci. U.S.A. 98(8) : 4403-4408.

    12. Ognibene TJ, Roberts ML, Southon JR and Vogel JS (2001). Low charge state AMS for high throughput 14C quantification. in Pliess, U. & Voges, R., eds. Synthesis and applications of isotopically labelled compounds (John Wiley & Sons, LTD.) v. 7 : 515-518.

    13. Brown K, Guenther EA, Dingley KH, Cosman M, Harvey CA, Shields SJ, and Turteltaub, KW (2001). Synthesis and spectroscopic characterization of site-specific 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine ligodeoxyribonucleotide adducts. Nucleic Acids Res. 29( 9) :1951-1959.

    14. Brown K, Hingerty BE, Guenther EA, Krishnan VV, Broyde S, Turteltaub KW, and Cosman M (2001). Solution structure of the 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine C8-deoxyguanosine adduct in duplex DNA. Proc. Natl. Acad. Sci. U.S.A. 98 :8507-8512.

    15. Buchholz BA, Vogel JS, Gilman SD, Gee SJ, Hammock BD, Hui XY and Wester RC, Maibach HI (2001). Determining an occupational dermal exposure biomarker for atrazine through measurement of metabolites in human urine by HPLC-accelerator mass spectrometry. in Maibach HI, ed. Toxicology of Skin (London; Taylor & Francis) 145-157.

    16. Vogel JS, Grant PG, Buchholz BA, Dingley KH and Turteltaub KW (2001). Attomole quantitation of protein separations with accelerator mass spectrometry. [Review] Electrophoresis 22(10) :2037-2045.

    17. Chiarappa-Zucca ML, Dingley KH, Roberts ML, Velsko CA and Love AH (2002). Sample Preparation for Quantitation of Tritium by Accelerator Mass Spectrometry. Anal. Chem. 74(24) :6285-90.

    18. Hickenbottom SJ, Lemke SL, Dueker SR, Lin Y, Follett JR, Carkeet C, Buchholz BA, Vogel JS and Clifford AJ (2002). Dual isotope test for assessing beta-carotene cleavage to vitamin A in humans. Eur. J. Clin. Nutrition 41 :141-147.

    19. Love AH, Hunt JR, Roberts ML, Southon JR, Chiarappa-Zucca ML and Dingley KH (2002). Use of tritium accelerator mass spectrometry for tree ring analysis. Environ. Sci. Technol. 36 :2848-2852.

    20. Müller HG, Su CL, Dueker SR, Lin Y, Clifford A, Buchholz BA and Vogel JS (2002). Semiparametric modeling of labeled cell kinetics, with an application to isotope labeling of erythrocytes. Biometrics 58 :937-945.

    21. Ognibene TJ, Bench G, Brown TA, Peaslee GF and Vogel JS (2002). A New Accelerator Mass Spectrometry System for 14C-Quantification of Biochemical Samples, Int. J. Mass Spectrom. 218 :255.

    22. Boocock DJ, Brown K, Gibbs AH, Sanchez E, Turteltaub KW and White INH (2002). Identification of Human CYP forms involved in the activation of Tamoxifen and irreversible binding to DNA. Carcinogenesis 23 :1897-1901.

    23. Lu CM, Burton DW, Fitzgerald RL, Deftos LJ, Buchholz BA, Vogel JS, and Herold, DA (2002). Mass spectrometric immunoassay for parathyroid related protein. Anal. Chem . 74 : 5507-5512.

    24. Vogel JS, Keating GA and Buchholz BA. (2002). Protein binding of isofluorophate in vivo after coexposure to multiple chemicals. Environ Health Pers. 110(Supp 6) :1031-1036.

    25. Williams KE, Carver TA, Mrianda JJL, Kautienen A, Vogel JS, Dingley K, Baldwin MA, Turteltaub KW and Burlingame AL (2002). Attomole detection of in vivo protein targets of benzene in mice. Mol. Cel. Proteomics 1(11) : 885-895.

    26. Ognibene TJ, Bench G, Vogel JS, Peaslee GF and Murov S. (2003). A High-Throughput Method for the Conversion of CO2 Obtained from Biochemical Samples to Graphite in Septa-Sealed Vials for 14C-AMS Quantification. Anal. Chem. 75(9) :2192-6.

    27. Lemke SL, Dueker SR, Lin Y, Carkeet C, Buchholz BA, Vogel JS and Clifford AJ (2003) Absorption and Retinol equivalence of beta-carotene in humans is influenced by dietary vitamin A intake. J. Lipid Res. 44 :1591-1600.

    28. Turesky RJ, Richoz J, Constable A. Curtis KD, Dingley KH and Turteltaub KW (2003). The effects of coffee on enzymes involved in metabolism of the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine in rats. Chem. Biol. Interact . 145(3) :251-265.

    29. Yao F, Mueller HG, Clifford AJ, Dueker SR, Follett JR, Lin Y, Buchholz BA and Vogel JS (2003). Shrinkage estimation for Functional Principal Components, with application to the population kinetics of plasma folate. Biometrics 59 :676-685.

    30. Turteltaub KW and Mani C (2003). Benzene metabolism in rodents at doses relevant to human exposure from urban air. Res. Rep. Health Eff. Inst. 113 :1-35.

    31. Grant PG, Palmblad M, Murov S, Hillegonds DJ, Ueda D, Vogel JS, and Bench G (2003). Alpha particle energy loss measurement of microgram depositions of biomolecules. Anal. Chem. 75(17) :4519-24.

    32. Vogel JS, Ognibene T, and Buchholz BA (2003). MS of "semi-" stable isotopes for absolute attomole quantitation. American Biotechnology Laboratory 21(10) :20-23.

    33. Martin EA, Brown K, Gaskell M, Al-Azzawi F, Garner RC, Boocock DJ, Mattock E, Pring DW, Dingley K, Turteltaub KW, Smith LL and White IN (2003). Tamoxifen DNA Damage Detected in Human Endometrium Using Accelerator Mass Spectrometry. Cancer Res . 63(23) : 8461-8465.

 


For information about this page contact:
Karolyn Burkhart-Schultz, burkhartschultz1@llnl.gov
UCRL-MI-140299